Product Information
LEVONOR-ETH ESTRAD 0.1-0.02 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1509 per EA under NDC 00378728753. Its NADAC has been published 629 times since Aug 6, 2014.
FDA first approved this application on Oct 9, 2013. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378728753
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200245FDA Approved
10/9/2013
TE Code
AB1
On Market Since
6/26/2014
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has been published 629 times since Aug 6, 2014, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1509 per EA |
|---|---|
| All-time high | $0.5937 (Apr 13, 2016) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.2446 |
| Average price | $0.2937 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 629 |
| Tracking since | Aug 6, 2014 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD 0.1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.1-0.02 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.1509 per EA (NDC 00378728753), effective Aug 19, 2026.
How has the price of LEVONOR-ETH ESTRAD 0.1-0.02 MG changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has declined 66.4%. It has been tracked across 629 weekly CMS publications since Aug 6, 2014.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Since Aug 6, 2014, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.5937 (Apr 13, 2016), with a median of $0.2446 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 25% below LEVONOR-ETH ESTRAD 0.1-0.02 MG.
Who manufactures LEVONOR-ETH ESTRAD 0.1-0.02 MG?
LEVONOR-ETH ESTRAD 0.1-0.02 MG (NDC 00378728753) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.